LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer

Abstract Long non-coding RNAs (lncRNAs) act as important regulators of tumorigenesis and development in bladder cancer. However, the underlying molecular mechanisms remain elusive. We previously identified a novel lncRNA signature related to immunity and progression in bladder cancer. Here we furthe...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Wenjie Luo, Jun Wang, Wenhao Xu, Chunguang Ma, Fangning Wan, Yongqiang Huang, Mengfei Yao, Hailiang Zhang, Yuanyuan Qu, Dingwei Ye, Yiping Zhu
Format: article
Langue:EN
Publié: Nature Publishing Group 2021
Sujets:
Accès en ligne:https://doaj.org/article/5b785dd5f167465eab103a298882c1cb
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
id oai:doaj.org-article:5b785dd5f167465eab103a298882c1cb
record_format dspace
spelling oai:doaj.org-article:5b785dd5f167465eab103a298882c1cb2021-11-07T12:05:03ZLncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer10.1038/s41419-021-04296-12041-4889https://doaj.org/article/5b785dd5f167465eab103a298882c1cb2021-11-01T00:00:00Zhttps://doi.org/10.1038/s41419-021-04296-1https://doaj.org/toc/2041-4889Abstract Long non-coding RNAs (lncRNAs) act as important regulators of tumorigenesis and development in bladder cancer. However, the underlying molecular mechanisms remain elusive. We previously identified a novel lncRNA signature related to immunity and progression in bladder cancer. Here we further explored the function of RP11-89, a lncRNA discovered in the previous signature. Loss- and gain-of function experiments were performed using CCK-8 assay, flow cytometry, Transwell assays, scratch tests and subcutaneous nude mouse models. High-throughput RNA sequencing was conducted to identify dysregulated genes in bladder cancer cells with RP11-89 knockdown or overexpression. Regulation of RP11-89 on miR-129-5p and PROM2 was explored through luciferase reporter assay, RIP assay and RNA pull-down assay. RP11-89 promoted cell proliferation, migration and tumorigenesis and inhibited cell cycle arrest via the miR-129-5p/PROM2 axis. We found that RP11-89 “sponges” miR-129-5p and upregulates PROM2. Elevated PROM2 in cells was associated with attenuated ferroptosis through iron export, formation of multivesicular bodies and less mitochondrial abnormalities. We demonstrated that RP11-89 is a novel tumorigenic regulator that inhibits ferroptosis via PROM2-activated iron export. RP11-89 may serve as a potential biomarker for targeted therapy in bladder cancer.Wenjie LuoJun WangWenhao XuChunguang MaFangning WanYongqiang HuangMengfei YaoHailiang ZhangYuanyuan QuDingwei YeYiping ZhuNature Publishing GrouparticleCytologyQH573-671ENCell Death and Disease, Vol 12, Iss 11, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Cytology
QH573-671
spellingShingle Cytology
QH573-671
Wenjie Luo
Jun Wang
Wenhao Xu
Chunguang Ma
Fangning Wan
Yongqiang Huang
Mengfei Yao
Hailiang Zhang
Yuanyuan Qu
Dingwei Ye
Yiping Zhu
LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer
description Abstract Long non-coding RNAs (lncRNAs) act as important regulators of tumorigenesis and development in bladder cancer. However, the underlying molecular mechanisms remain elusive. We previously identified a novel lncRNA signature related to immunity and progression in bladder cancer. Here we further explored the function of RP11-89, a lncRNA discovered in the previous signature. Loss- and gain-of function experiments were performed using CCK-8 assay, flow cytometry, Transwell assays, scratch tests and subcutaneous nude mouse models. High-throughput RNA sequencing was conducted to identify dysregulated genes in bladder cancer cells with RP11-89 knockdown or overexpression. Regulation of RP11-89 on miR-129-5p and PROM2 was explored through luciferase reporter assay, RIP assay and RNA pull-down assay. RP11-89 promoted cell proliferation, migration and tumorigenesis and inhibited cell cycle arrest via the miR-129-5p/PROM2 axis. We found that RP11-89 “sponges” miR-129-5p and upregulates PROM2. Elevated PROM2 in cells was associated with attenuated ferroptosis through iron export, formation of multivesicular bodies and less mitochondrial abnormalities. We demonstrated that RP11-89 is a novel tumorigenic regulator that inhibits ferroptosis via PROM2-activated iron export. RP11-89 may serve as a potential biomarker for targeted therapy in bladder cancer.
format article
author Wenjie Luo
Jun Wang
Wenhao Xu
Chunguang Ma
Fangning Wan
Yongqiang Huang
Mengfei Yao
Hailiang Zhang
Yuanyuan Qu
Dingwei Ye
Yiping Zhu
author_facet Wenjie Luo
Jun Wang
Wenhao Xu
Chunguang Ma
Fangning Wan
Yongqiang Huang
Mengfei Yao
Hailiang Zhang
Yuanyuan Qu
Dingwei Ye
Yiping Zhu
author_sort Wenjie Luo
title LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer
title_short LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer
title_full LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer
title_fullStr LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer
title_full_unstemmed LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer
title_sort lncrna rp11-89 facilitates tumorigenesis and ferroptosis resistance through prom2-activated iron export by sponging mir-129-5p in bladder cancer
publisher Nature Publishing Group
publishDate 2021
url https://doaj.org/article/5b785dd5f167465eab103a298882c1cb
work_keys_str_mv AT wenjieluo lncrnarp1189facilitatestumorigenesisandferroptosisresistancethroughprom2activatedironexportbyspongingmir1295pinbladdercancer
AT junwang lncrnarp1189facilitatestumorigenesisandferroptosisresistancethroughprom2activatedironexportbyspongingmir1295pinbladdercancer
AT wenhaoxu lncrnarp1189facilitatestumorigenesisandferroptosisresistancethroughprom2activatedironexportbyspongingmir1295pinbladdercancer
AT chunguangma lncrnarp1189facilitatestumorigenesisandferroptosisresistancethroughprom2activatedironexportbyspongingmir1295pinbladdercancer
AT fangningwan lncrnarp1189facilitatestumorigenesisandferroptosisresistancethroughprom2activatedironexportbyspongingmir1295pinbladdercancer
AT yongqianghuang lncrnarp1189facilitatestumorigenesisandferroptosisresistancethroughprom2activatedironexportbyspongingmir1295pinbladdercancer
AT mengfeiyao lncrnarp1189facilitatestumorigenesisandferroptosisresistancethroughprom2activatedironexportbyspongingmir1295pinbladdercancer
AT hailiangzhang lncrnarp1189facilitatestumorigenesisandferroptosisresistancethroughprom2activatedironexportbyspongingmir1295pinbladdercancer
AT yuanyuanqu lncrnarp1189facilitatestumorigenesisandferroptosisresistancethroughprom2activatedironexportbyspongingmir1295pinbladdercancer
AT dingweiye lncrnarp1189facilitatestumorigenesisandferroptosisresistancethroughprom2activatedironexportbyspongingmir1295pinbladdercancer
AT yipingzhu lncrnarp1189facilitatestumorigenesisandferroptosisresistancethroughprom2activatedironexportbyspongingmir1295pinbladdercancer
_version_ 1718443547565228032